cobaltous chloride has been researched along with celecoxib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hofman, FM; Jabbour, M; Kardosh, A; Liu, YT; Pyrko, P; Schönthal, AH; Soriano, N | 1 |
| Cai, N; Liu, NN; Zhao, N | 1 |
2 other study(ies) available for cobaltous chloride and celecoxib
| Article | Year |
|---|---|
Reduced survivin expression and tumor cell survival during chronic hypoxia and further cytotoxic enhancement by the cyclooxygenase-2 inhibitor celecoxib.
Topics: Celecoxib; Cell Hypoxia; Cell Line, Tumor; Cobalt; Cyclooxygenase 2 Inhibitors; Endoplasmic Reticulum Chaperone BiP; Humans; Inhibitor of Apoptosis Proteins; Microtubule-Associated Proteins; Neoplasm Proteins; Neoplasms; Pyrazoles; Sulfonamides; Survivin | 2007 |
The effect and mechanism of celecoxib in hypoxia-induced survivin up-regulation in HUVECs.
Topics: Celecoxib; Cell Hypoxia; Cell Proliferation; Cobalt; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Gene Expression Regulation; Genistein; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Inhibitor of Apoptosis Proteins; Survivin; Up-Regulation | 2015 |